Integrated Diabetes Management Protocol Using Smartphone

Diabetes Clinical Trial

Official title:

Integrated Diabetes Management Protocol Using Smartphone

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02362607
• Other study ID #: 2014-06-006
• Status: Completed
• Phase: N/A
• First received: February 2, 2015
• Last updated: February 3, 2016
• Start date: February 2015

Study information

• Verified date: February 2016
• Source: Chungbuk National University
• Contact: n/a
• Is FDA regulated: No
• Health authority: South Korea: Ministry of Food and Drug Safety
• Study type: Interventional

Clinical Trial Summary

The investigators aim to assess whether using integrated diabetes management protocol using smartphone would increase glucose control among diabetes patients.

Description:

Smartphones and digital healthcare is expected to provide better diabetes care. The investigators aim to assess whether using integrated diabetes management protocol using smartphone would increase glucose control among diabetes patients.

Smartphone apps for food diary, activity monitor, blood glucose will be used for three months.

Blood glucose control and patient satisfaction will be assessed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. primary completion date: October 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• Type 2 diabetes, type 1 diabetes, gestational diabetes

Exclusion Criteria:

• Medications which interfere glucose control

• Cancer

• Chronic kidney injury

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Diabetes

Intervention

Behavioral:
• Integrated Diabetes Management Protocol

• Standard Diabetes Management Protocol

Locations

Country	Name	City	State
Korea, Republic of	Chungbuk National University	Cheongju	Chungcheongbuk-Do

Sponsors (1)

Lead Sponsor	Collaborator
Chungbuk National University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood Glucose Control Status Measured by HbA1c	Blood test results for HbA1c after three months.	After three months	No
Secondary	Patient Satisfaction Measured by Questionnaire	Summary of Diabetes Self-Care Activities Measure (SDSCA) Questionnaire (Toobert et al., 2000)	After three months	No